These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 262631)

  • 1. [Treatment of acute and chronic liver diseases with calcium-2,2'-disulfohexanoate].
    Ravetta A
    Clin Ter; 1979 Aug; 90(4):357-68. PubMed ID: 262631
    [No Abstract]   [Full Text] [Related]  

  • 2. [Calcium-2,2'-disulfohexanoate in the treatment of liver diseases: study of a series of 15 patients].
    Piludu G; Perpignano G
    Clin Ter; 1981 May; 97(4):377-82. PubMed ID: 7249568
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in some blood chemical parameters in patients with chronic liver diseases treated with calcium-2,2'-disulfohexanoate].
    Turpini R; Scotti A; Brusoni V; Perego M
    Clin Ter; 1980 Jun; 93(6):689-94. PubMed ID: 7428323
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical evaluation of the activity of calcium-2,2'-disulfohexanoate in liver insufficiency].
    Romboli L; Leonardi R; Bertucci P; Fortunati P
    Clin Ter; 1978 Nov; 87(3):265-72. PubMed ID: 753574
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of calcium 2,2'-disulfohexanoate in chronic hepatopathies].
    Ortolan A; Martin A; Pieropan G
    Minerva Dietol Gastroenterol; 1978; 24(1):7-11. PubMed ID: 740272
    [No Abstract]   [Full Text] [Related]  

  • 6. [Action of calcium 2,2'-disulfohexanoate on the course of acute viral hepatitis: double-blind study].
    Calonghi G; Sueri L
    Clin Ter; 1982 Nov; 103(3):273-82. PubMed ID: 6759010
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hepatotropic action of calcium 2,2'-disulfohexanoate].
    Ferrari B; Della Seta L; Boscaini M; Piccini Leopardi M
    Clin Ter; 1978 Apr; 85(2):163-72. PubMed ID: 657746
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic effects of calcium-2,2'-disulfohexanoate in hepatic cirrhosis].
    Cangiano C; Angelico M; Rossi Fanelli F
    Clin Ter; 1978 Aug; 86(4):337-53. PubMed ID: 737963
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of therapeutic activity of a new pharmacologic combination in patients with chronic liver and debilitating diseases].
    Pasotti C; Buniva G; Carpinella G
    Clin Ter; 1971 Mar; 56(5):427-39. PubMed ID: 5564990
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic study of hexanoic acid in tympanoplasties].
    Charachon R; Junien-Lavillauroy PC; Serero C; Accoyer B
    JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1975 May; 24(5):401-2. PubMed ID: 126284
    [No Abstract]   [Full Text] [Related]  

  • 11. [The action of amino acids and their keto analogs on urea and ketone body formation in rat liver sections in chronic uremia].
    Spellerberg P; Lamberts B; Bauerdick H; Ochs HG; Heintz R
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1247-9. PubMed ID: 611828
    [No Abstract]   [Full Text] [Related]  

  • 12. [Parenteral magnesium treatment in chronic liver diseases].
    Merker G; Selisko O
    Z Gesamte Inn Med; 1967 Mar; 22(6):182-5. PubMed ID: 5593100
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of the fraction of hepatocyte depuration before and after treatment with alpha-mercaptopropionylglycine in chronic hepatopathies].
    Cortinovis A; Paolini FA; Crippa A
    Minerva Med; 1979 Dec; 70(54):3709-13. PubMed ID: 523002
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical study on the treatment of liver disease with glucocorticoids].
    Oda T; Suzuki H; Naito C; Yamanada M; Oka H
    Saishin Igaku; 1969 Oct; 24(10):2119-29. PubMed ID: 5349229
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the results of the treatment of chronic liver disease with a liver extract lysate (Solcohepsyl)].
    Grabner G; Pokorny D
    Wien Z Inn Med; 1965 Nov; 46(11):460-4. PubMed ID: 5330278
    [No Abstract]   [Full Text] [Related]  

  • 16. [Influence of treatment with nucleosides, liver extract and vitamin B 12 on various hepatic functional defects and on cellular proliferation of bone marrow in chronic liver diseases].
    Turpini R
    Clin Ter; 1970 Apr; 53(1):9-23. PubMed ID: 5472849
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of the liver cell clearance fraction before and after treatment with alpha-mercaptopropionylglycine in chronic hepatopathies].
    Cortinovis A; Paolini FA; Crippa A
    Arch Sci Med (Torino); 1979; 136(4):497-508. PubMed ID: 550750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On the therapy of liver diseases with ornithine aspartate].
    Melzer H; Weber D; Wotzka R
    Med Klin; 1969; 64(35):1541-4. PubMed ID: 5354488
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of the short-term treatment of active chronic liver diseases with betamethasone].
    Sarti F; Milandri GL; Giuliani Piccari G; Formica G; Spongano P; Accardo P
    G Clin Med; 1982 Jun; 63(6):392-400. PubMed ID: 6816654
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of liver damage during a course of tuberculosis and chronic pulmonary diseases. Necessity of treatment and new trends].
    Mariani B; Marchioni GF; Capitolo S
    Minerva Med; 1974 Aug; 65(57):2977-89. PubMed ID: 4603931
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.